Silk Road Medical IncSILK

時価総額
$10.8億
PER
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
2023年
12月31日
Net loss-52-47-50-55-56
Other Depreciation and Amortization-1123
Stock-based compensation expense37152539
Amortization of premiums (accretion of discounts) on investments, net0-0-116
Amortization of Debt Issuance Costs and Discounts00000
Amortization of right-of-use asset-1111
Paid-in-Kind Interest10-11
Loss on extinguishment of debt--1--0-
Loss on disposal of property and equipment--0-0-0-0
Accounts Receivable, Credit Loss Expense (Reversal)0-00-00
Inventory Write-down00000
Accounts receivable20366
Inventories526111
Prepaid expenses and other current assets1-0112
Other assets-1-0000
Accounts payable11-113
Accrued liabilities50423
Other liabilities-10-1-1-1
Repayment of interest paid in kind-4---
Net cash used in operating activities-30-42-39-33-32
Purchases of property and equipment11552
Proceeds from sale of property and equipment--0--
Purchases of investments6980-168175
Proceeds from maturity of investments-717711169
Net cash provided by (used in) investing activities-70-973-162-7
Proceeds from Issuance Initial Public Offering10971-109-
Proceeds from long-term debt, net-49-74-
Proceeds from issuance of common stock35764
Principal repayment of long-term debt-40-49-
Payments of prepayment penalty and lender fees-2---
Proceeds from Noncontrolling Interests--0--
Proceeds from Noncontrolling Interests--0--
Net cash provided by financing activities1148271404
Net cash provided by financing activities1148271404
Net change in cash, cash equivalents and restricted cash143041-55-35
Cash paid for interest48246
Capital Expenditures Incurred but Not yet Paid00100
Unpaid deferred offering costs-0---
Right-of-use asset obtained in exchange for lease obligation4-313
Right-of-use asset obtained in exchange for lease obligation4-313